Back To White Oak: US FDA Adcomms Go Fully In-Person, Starting With Antimicrobials Panel
Executive Summary
The 9 September meeting on Iterum Therapeutics' oral sulopenem product for uncomplicated urinary tract infections marks the first fully in-person advisory committee drug review since the COVID-19 pandemic hit in early 2020.